· The Therapeutic Goods and Biotechnology sector is worth up to $4 billion in Australia
· The sector in NSW is beginning to become more organised with a lot of effort through
DSRD
· There is no foci as with other states such as Melbourne or Brisbane
· Melbourne has the BioMelbourne Cluster with 500 members
· There is no land or regional focus developed in Sydney despite 10 years of efforts
· Sydney is disconnected without any real networking between disconnected companies and
research teams
· Development within Therapeutic and Biotech clusters have proven success in bringing
large increases in investment and capital into a genuine region e.g. Western Ireland,
BioMelbourne
skip to main |
skip to sidebar
The Hunter BioTx group has a strong foundation for further growth. For instance, 81.8 percent of
businesses stated that they were privately owned, 58.3 percent stated that they had been in
business for over 10 years and 33.3 percent employed well over 50 persons.
Marketing skills are in need of better utilisation. Only a small proportion of businesses surveyed
utilised newspaper and television and none utilised radio. The majority of businesses utilised in
house marketing strategies such as field staff which may help to explain why so many end-product
users asked the question “What is biotechnology” when surveyed.
Multinational companies and a lack of consumer expertise were primarily seen as threats.
Competitors are seen to be diverse from small, specific units for smaller organisations to larger
multinationals for the larger organisations.
The majority of businesses surveyed reflected healthy organisational outlooks. Most organisations
surveyed viewed themselves as being good to excellent in comparison to their contemporaries.
Some of the latest developments in the Hunter BioTx group organisations surveyed included OH & S
requirements to develop retractables, innovative packaging, environmental accountability,
bioinformatics, vaccine developments and medical devices. Global consolidation was also viewed as
a recent development.
The pricing and supply of raw materials, finance and the time it takes to develop products and get
it passed through TGA were some of the main obstacles faced by organisations surveyed.
It would appear that marketing is an under-utilised factor in the Hunter BioTx group. Overall,
better marketing skills and utilisation would help to alleviate two substantial problems of
multinational threat and recruitment of staff by placing emphasis on marketing not only descriptive
information, but by selling it in the form of university recruitment for education.
A blog spot for the latested updates on the Hunter Biotechnology and Therapeautics Group.
Hunter BioTx Launch 2008
REPORT FINDINGS
The Hunter BioTx group has a strong foundation for further growth. For instance, 81.8 percent of
businesses stated that they were privately owned, 58.3 percent stated that they had been in
business for over 10 years and 33.3 percent employed well over 50 persons.
Marketing skills are in need of better utilisation. Only a small proportion of businesses surveyed
utilised newspaper and television and none utilised radio. The majority of businesses utilised in
house marketing strategies such as field staff which may help to explain why so many end-product
users asked the question “What is biotechnology” when surveyed.
Multinational companies and a lack of consumer expertise were primarily seen as threats.
Competitors are seen to be diverse from small, specific units for smaller organisations to larger
multinationals for the larger organisations.
The majority of businesses surveyed reflected healthy organisational outlooks. Most organisations
surveyed viewed themselves as being good to excellent in comparison to their contemporaries.
Some of the latest developments in the Hunter BioTx group organisations surveyed included OH & S
requirements to develop retractables, innovative packaging, environmental accountability,
bioinformatics, vaccine developments and medical devices. Global consolidation was also viewed as
a recent development.
The pricing and supply of raw materials, finance and the time it takes to develop products and get
it passed through TGA were some of the main obstacles faced by organisations surveyed.
It would appear that marketing is an under-utilised factor in the Hunter BioTx group. Overall,
better marketing skills and utilisation would help to alleviate two substantial problems of
multinational threat and recruitment of staff by placing emphasis on marketing not only descriptive
information, but by selling it in the form of university recruitment for education.
Greg Whiteley
Greg Whiteley has been the Managing Director of Whiteley Corporation since 1992 and is the business champion of the Hunter BioTx Group formation.
Kathie Heyman
Kathie Heyman acts as a business consultant for the Hunter BioTx Group.
No comments:
Post a Comment